易方达中证A50增强策略ETF

Search documents
近20只,“同台竞技”
Zhong Guo Ji Jin Bao· 2025-06-16 03:28
Group 1 - A total of 17 new funds were launched in the week from June 16 to June 20, with index funds being the main focus of issuance [1][2] - On June 16 alone, 11 new products were introduced, including various ETFs and index funds [1][2] - The previous week saw 15 new funds established, with a total issuance scale of nearly 9 billion yuan, predominantly driven by bond funds, which accounted for over 85% of the total [1][3] Group 2 - Among the new funds, the Huatai-PineBridge Hong Kong Stock Connect Medical Selection Fund focuses on investing in quality listed companies related to the medical industry [2] - The Ping An Yingxuan 90-Day Holding Fund is an ETF-FOF product that allocates over 80% of its funds to bond ETFs while also investing in various risk assets [2] - Several funds, including the Morgan Stanley CSI 300 Free Cash Flow Linked Fund and the Fortune Growth Enterprise AI ETF, have a maximum fundraising limit of 8 billion units [2] Group 3 - Last week, two interbank certificate funds raised a total of 4.265 billion yuan, representing 46.74% of the total issuance volume [3] - The top-performing fund, the People's Insurance CSI Interbank Certificate AAA Index 7-Day Holding Fund, raised 3.910 billion yuan [3] - The Jia Shi Hui Ming 7-Month Closed Pure Bond Fund raised 2.746 billion yuan, making it the second-largest new fund by issuance scale for the week [3]
每周基金发行前瞻:新发17只产品 指数型产品数据居前
Sou Hu Cai Jing· 2025-06-13 08:47
Group 1 - A total of 17 new public funds will be launched from June 16 to June 20, involving 15 fund companies, with an average fundraising period of approximately 21 days [1][5] - Among the new funds, equity funds dominate with 12 offerings, followed by 3 bond funds, primarily consisting of index funds [2][4] - The newly issued stock funds mainly include 10 passive index funds and 2 enhanced index products, featuring ETFs such as the Fortune Creation Board AI ETF and the Huabao Hang Seng Hong Kong Stock Connect Innovative Drug Selection ETF [2][4] Group 2 - Only one actively managed equity product will be issued during this period, which is the Huatai-PB Hong Kong Stock Connect Medical Selection Fund, focusing on quality listed companies in the medical industry [4] - The number of FOF funds issued is also limited to one, which is the Ping An Fund's Ping An Yingxuan 90-day Holding Bond FOF [4] - Notably, the issuance of new products includes two from E Fund and Tianhong Fund, with E Fund launching the E Fund National Certificate Value 100 ETF and the E Fund CSI A50 Enhanced Strategy ETF [5] Group 3 - The fundraising cap for 10 of the new products has been announced, with some reaching up to 8 billion units, such as the Southern CSI Hong Kong Stock Connect Technology ETF and the Morgan Shanghai-Shenzhen 300 Free Cash Flow Linked Fund [5][8] - The average fundraising duration for the 17 products is about 21 days, with the E Fund CSI A50 Enhanced Strategy ETF and the Invesco CSI Science and Technology Innovation Board 200 Index having a longer subscription period of 92 days [8] - The management fee for the Huatai-PB Hong Kong Stock Connect Medical Selection Fund is relatively high, reaching an annual rate of 1.2% [8]